Q03WY1 AF NFT

Glycine--tRNA ligase beta subunit

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihdktwzxmcdfbxhmpkp7waoieyoxmdcjvbyr4rpftdnhcydat45x4/metadata.json
IPFS of structure file: 
bafybeihsysli2hsh4q7mtepb222bq2g5wmmso63yyjerrpuojytj5lvmgq/AF-Q03WY1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x4d07E6a23DeB6B95bd9b90EcB67368b7e8D3B77e
First NFT owner address (bech32): 
genesis1f5r7dg3aad4et0vmjrktvumgkl5d8dm7pxdzfr
Current NFT ID #447665 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
447665
Accession (UniProt):
Q03WY1
Name::
Glycine--tRNA ligase beta subunit
Experimental Method:
Predicted structure
Sequence source:
Leuconostoc mesenteroides subsp. mesenteroides (strain ATCC 8293 / DSM 20343 / BCRC 11652 / CCM 1803 / JCM 6124 / NCDO 523 / NBRC 100496 / NCIMB 8023 / NCTC 12954 / NRRL B-1118 / 37Y)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q03WY1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q03WY1|SYGB_LEUMM Glycine--tRNA ligase beta subunit OS=Leuconostoc mesenteroides subsp. mesenteroides (strain ATCC 8293 / DSM 20343 / BCRC 11652 / CCM 1803 / JCM 6124 / NCDO 523 / NBRC 100496 / NCIMB 8023 / NCTC 12954 / NRRL B-1118 / 37Y) OX=203120 GN=glyS PE=3 SV=1 MSTFLLEIGLEEVPAHLVTSSENQLIERTRNFLAEHRLTVGAINPYSTPRRLAVELTDVAEKSESLSEEKRGPSIERAKDANGEWTKAAMGFARGQGATPDDFETRDGYVWLTKHTEGVPAKDILVKIGAEVVSEMKFSTYMKWANNAFLYVRPIRWLVALFDKEVVDFHVLDVQTGRVTRGHRFLSNEHVEISSADDYVSKLESASVVVNAEVRKNAIRSQLTAIAKQNNWSLELDTDAAQNLLEEVNNIVEWPTAFAGTFDKKYLEIPDEVLITSMREHQRFFFVTNHDGKLLPHFLSVRNGNKEHLDNVIAGNEKVLVARLEDAEFFYKEDQTKTIADYMEKVKKLVFHEKIGTVYEHMQRTGVLAQALAQSLNFDEQQLSNVSRAAEIYKFDLMTGMVGEFDELQGIMGEHYAKLFGENPAVAAAIKEHYMPTSATGKIAESDIGAVLAVADKLDAIVTFFAADLTPSGSNDPYGLRRAATGIVRTLQEKNWHIALKPVLTQFAQSQGEVAAADITAVLEFILDRVRKLTLDDGVRQDLVSAGVSRSGNTDVVYLIDRINVLAAHSKDNDFRDVIESLTRVDRLAVKQLTNDSVDPSLFENDAEKELYQATYALNLSHLVKEGADEVYTTLAGLQSPISTYFEATMVNTENAAVKNNRYAQLNVIHRLISELGDLEQIVIK